Minority report – false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-11-18

AUTHORS

S. Ciatto, N. Houssami, D. Ambrogetti, R. Bonardi, G. Collini, M. Rosselli Del Turco

ABSTRACT

AimWe studied imaging, pathology and diagnostic aspects of false negative assessment (FNA) in women recalled for suspicious screening mammography.MethodSubjects were women aged 50–69 years undergoing biennial screening mammography within the Florence District screening programme from January 1992–December 2001 (339,953 consecutive screens). We identified all cancers occurring in women recalled to assessment and ascertained, and reviewed, all cases considered as negative on assessment and subsequently diagnosed with breast cancer. We compared imaging features, tumour histology and stage, and diagnostic testing on assessment for all women with cancer, and presentation and length of delay in women falsely negative on assessment.ResultsEleven thousand six hundred and twenty four women were recalled to diagnostic assessment (recall rate = 3.4%) predominantly for suspicious mammography (9,216 positive screens). Breast cancer was missed in 57 cases: a FNA rate of 0.50% (0.37–0.62%) and comprising 4.1% (3.0–5.1%) of cancers occurring in women recalled after a positive screen. Two types of abnormalities were significantly more frequent in FNA cases than cancers detected at assessment: mass with regular borders (21.1 vs. 5.6%, p = 10−5), and asymmetrical density (22.8 vs. 5.4%, p = 10−5). On review 56% of FNAs were benign or probably benign BI-RADS categories. FNA occurred in 1.4% of early recalls and in 0.4% of initial assessment (p=0.0001). Significantly fewer tests were performed when assessing missed cancers than detected cancers with the most significant difference noted for FNAC (29.8 vs. 96.0%, p=10−6); mammography as the only evaluation on assessment was more frequent in missed cancers (31.5% vs 0.2%, p = 10−6). The 57 missed cases were subsequently diagnosed at early recall (2 cases), next biennial screen (11 cases), or as interval breast cancers (44 cases) with a mean delay in diagnosis of 628 days. Tumour histology, size and nodal status did not significantly differ between cancers missed and cancers diagnosed on assessment.ConclusionFalse negatives on assessment represent a minority group in whom screening has failed. They might be reduced by adopting a more intensive diagnostic approach to assessment. Although there was no evidence of a worse prognosis in cancers missed at assessment, the delay in diagnosis is substantial and may impact long-term outcomes. More... »

PAGES

37-43

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10549-006-9425-3

DOI

http://dx.doi.org/10.1007/s10549-006-9425-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036835572

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17115112


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biopsy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "False Negative Reactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mammography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mass Screening", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ciatto", 
        "givenName": "S.", 
        "id": "sg:person.01174274056.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174274056.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Public Health, Screening & Test Evaluation Program, School of Public Health, Edward Ford Building A27, University of Sydney, 2006, Sydney, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1013.3", 
          "name": [
            "School of Public Health, Screening & Test Evaluation Program, School of Public Health, Edward Ford Building A27, University of Sydney, 2006, Sydney, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Houssami", 
        "givenName": "N.", 
        "id": "sg:person.0747474743.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747474743.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ambrogetti", 
        "givenName": "D.", 
        "id": "sg:person.01012362050.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012362050.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bonardi", 
        "givenName": "R.", 
        "id": "sg:person.0663211456.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663211456.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Collini", 
        "givenName": "G.", 
        "id": "sg:person.0660537165.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660537165.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Del Turco", 
        "givenName": "M. Rosselli", 
        "id": "sg:person.01310346446.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310346446.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6602158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051991679", 
          "https://doi.org/10.1038/sj.bjc.6602158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-006-9289-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049312084", 
          "https://doi.org/10.1007/s10549-006-9289-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-11-18", 
    "datePublishedReg": "2006-11-18", 
    "description": "AimWe studied imaging, pathology and diagnostic aspects of false negative assessment (FNA) in women recalled for suspicious screening mammography.MethodSubjects were women aged 50\u201369\u00a0years undergoing biennial screening mammography within the Florence District screening programme from January 1992\u2013December 2001 (339,953 consecutive screens). We identified all cancers occurring in women recalled to assessment and ascertained, and reviewed, all cases considered as negative on assessment and subsequently diagnosed with breast cancer. We compared imaging features, tumour histology and stage, and diagnostic testing on assessment for all women with cancer, and presentation and length of delay in women falsely negative on assessment.ResultsEleven thousand six hundred and twenty four women were recalled to diagnostic assessment (recall rate\u00a0=\u00a03.4%) predominantly for suspicious mammography (9,216 positive screens). Breast cancer was missed in 57 cases: a FNA rate of 0.50% (0.37\u20130.62%) and comprising 4.1% (3.0\u20135.1%) of cancers occurring in women recalled after a positive screen. Two types of abnormalities were significantly more frequent in FNA cases than cancers detected at assessment: mass with regular borders (21.1 vs. 5.6%, p\u00a0=\u00a010\u22125), and asymmetrical density (22.8 vs. 5.4%, p\u00a0=\u00a010\u22125). On review 56% of FNAs were benign or probably benign BI-RADS categories. FNA occurred in 1.4% of early recalls and in 0.4% of initial assessment (p=0.0001). Significantly fewer tests were performed when assessing missed cancers than detected cancers with the most significant difference noted for FNAC (29.8 vs. 96.0%, p=10\u22126); mammography as the only evaluation on assessment was more frequent in missed cancers (31.5% vs 0.2%, p\u00a0=\u00a010\u22126). The 57 missed cases were subsequently diagnosed at early recall (2 cases), next biennial screen (11 cases), or as interval breast cancers (44 cases) with a mean delay in diagnosis of 628\u00a0days. Tumour histology, size and nodal status did not significantly differ between cancers missed and cancers diagnosed on assessment.ConclusionFalse negatives on assessment represent a minority group in whom screening has failed. They might be reduced by adopting a more intensive diagnostic approach to assessment. Although there was no evidence of a worse prognosis in cancers missed at assessment, the delay in diagnosis is substantial and may impact long-term outcomes.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10549-006-9425-3", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6718511", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1092777", 
        "issn": [
          "0167-6806", 
          "1573-7217"
        ], 
        "name": "Breast Cancer Research and Treatment", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "105"
      }
    ], 
    "keywords": [
      "suspicious screening mammography", 
      "false negative assessments", 
      "breast cancer", 
      "screening mammography", 
      "long-term outcomes", 
      "early recall", 
      "interval breast cancers", 
      "biennial screening mammography", 
      "BI-RADS categories", 
      "suspicious mammography", 
      "biennial screens", 
      "nodal status", 
      "tumor histology", 
      "worse prognosis", 
      "missed cancers", 
      "pathological features", 
      "regular borders", 
      "positive screen", 
      "types of abnormalities", 
      "Florence District", 
      "diagnostic aspects", 
      "cancer", 
      "diagnostic testing", 
      "FNA cases", 
      "diagnostic approach", 
      "asymmetrical density", 
      "diagnostic assessment", 
      "women", 
      "initial assessment", 
      "diagnosis", 
      "breast assessment", 
      "mammography", 
      "significant differences", 
      "length of delay", 
      "histology", 
      "mean delay", 
      "assessment", 
      "associated delay", 
      "only evaluation", 
      "imaging", 
      "prognosis", 
      "FNAC", 
      "AimWe", 
      "cases", 
      "abnormalities", 
      "pathology", 
      "outcomes", 
      "minority groups", 
      "MethodSubjects", 
      "presentation", 
      "days", 
      "screening", 
      "status", 
      "recall", 
      "group", 
      "years", 
      "delay", 
      "evidence", 
      "screen", 
      "differences", 
      "testing", 
      "evaluation", 
      "negatives", 
      "rate", 
      "test", 
      "features", 
      "stage", 
      "mass", 
      "program", 
      "categories", 
      "border", 
      "negative assessment", 
      "district", 
      "types", 
      "length", 
      "aspects", 
      "size", 
      "approach", 
      "density", 
      "hundreds", 
      "ResultsEleven thousand six hundred", 
      "thousand six hundred", 
      "six hundred", 
      "FNA rate", 
      "review 56", 
      "benign BI-RADS categories", 
      "next biennial screen", 
      "intensive diagnostic approach", 
      "Minority report \u2013 false negative breast assessment", 
      "report \u2013 false negative breast assessment", 
      "negative breast assessment"
    ], 
    "name": "Minority report \u2013 false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis", 
    "pagination": "37-43", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036835572"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10549-006-9425-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17115112"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10549-006-9425-3", 
      "https://app.dimensions.ai/details/publication/pub.1036835572"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_429.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10549-006-9425-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10549-006-9425-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10549-006-9425-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10549-006-9425-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10549-006-9425-3'


 

This table displays all metadata directly associated to this object as RDF triples.

265 TRIPLES      22 PREDICATES      135 URIs      124 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10549-006-9425-3 schema:about N0fa0f243bae34018a92df26e478c4f5c
2 N422d7fd54aa44d3a99469b8b7dfb6f7e
3 N4c4a6b1561574276ac938230915042d7
4 N640f66a8b73649cf810812391baed60c
5 N6f16fedcefeb4aa1a86876f4ae950948
6 N75135c8caade4e8c8bb434eb9709bda1
7 N7bc273facc8542e4bc5801e30b27e539
8 N8410e26deb414324876f93e312eeb484
9 N8c8d4c74fb1c4d00954ec5fbb52030f7
10 N8dc6479113d745eeab102ab636c5131c
11 N9246369ee7d74fac804f6f8f67d799e7
12 Na71934b005ba4ea580d65987efc24474
13 Nb6693fef86134accb80be87bcb65b01e
14 Nb8c882fd6428436f95d5e0d051dc9c3d
15 Nc42f06eb941d409fb59b394d78433dda
16 anzsrc-for:11
17 anzsrc-for:1112
18 anzsrc-for:1117
19 schema:author N3ddd8656b2f04e679d3c86b256ee5dbd
20 schema:citation sg:pub.10.1007/s10549-006-9289-6
21 sg:pub.10.1038/sj.bjc.6602158
22 schema:datePublished 2006-11-18
23 schema:datePublishedReg 2006-11-18
24 schema:description AimWe studied imaging, pathology and diagnostic aspects of false negative assessment (FNA) in women recalled for suspicious screening mammography.MethodSubjects were women aged 50–69 years undergoing biennial screening mammography within the Florence District screening programme from January 1992–December 2001 (339,953 consecutive screens). We identified all cancers occurring in women recalled to assessment and ascertained, and reviewed, all cases considered as negative on assessment and subsequently diagnosed with breast cancer. We compared imaging features, tumour histology and stage, and diagnostic testing on assessment for all women with cancer, and presentation and length of delay in women falsely negative on assessment.ResultsEleven thousand six hundred and twenty four women were recalled to diagnostic assessment (recall rate = 3.4%) predominantly for suspicious mammography (9,216 positive screens). Breast cancer was missed in 57 cases: a FNA rate of 0.50% (0.37–0.62%) and comprising 4.1% (3.0–5.1%) of cancers occurring in women recalled after a positive screen. Two types of abnormalities were significantly more frequent in FNA cases than cancers detected at assessment: mass with regular borders (21.1 vs. 5.6%, p = 10−5), and asymmetrical density (22.8 vs. 5.4%, p = 10−5). On review 56% of FNAs were benign or probably benign BI-RADS categories. FNA occurred in 1.4% of early recalls and in 0.4% of initial assessment (p=0.0001). Significantly fewer tests were performed when assessing missed cancers than detected cancers with the most significant difference noted for FNAC (29.8 vs. 96.0%, p=10−6); mammography as the only evaluation on assessment was more frequent in missed cancers (31.5% vs 0.2%, p = 10−6). The 57 missed cases were subsequently diagnosed at early recall (2 cases), next biennial screen (11 cases), or as interval breast cancers (44 cases) with a mean delay in diagnosis of 628 days. Tumour histology, size and nodal status did not significantly differ between cancers missed and cancers diagnosed on assessment.ConclusionFalse negatives on assessment represent a minority group in whom screening has failed. They might be reduced by adopting a more intensive diagnostic approach to assessment. Although there was no evidence of a worse prognosis in cancers missed at assessment, the delay in diagnosis is substantial and may impact long-term outcomes.
25 schema:genre article
26 schema:inLanguage en
27 schema:isAccessibleForFree false
28 schema:isPartOf N35dd83d54acb401e942a1a860cacb92f
29 Nc19187fa32d243879601a0f981b24708
30 sg:journal.1092777
31 schema:keywords AimWe
32 BI-RADS categories
33 FNA cases
34 FNA rate
35 FNAC
36 Florence District
37 MethodSubjects
38 Minority report – false negative breast assessment
39 ResultsEleven thousand six hundred
40 abnormalities
41 approach
42 aspects
43 assessment
44 associated delay
45 asymmetrical density
46 benign BI-RADS categories
47 biennial screening mammography
48 biennial screens
49 border
50 breast assessment
51 breast cancer
52 cancer
53 cases
54 categories
55 days
56 delay
57 density
58 diagnosis
59 diagnostic approach
60 diagnostic aspects
61 diagnostic assessment
62 diagnostic testing
63 differences
64 district
65 early recall
66 evaluation
67 evidence
68 false negative assessments
69 features
70 group
71 histology
72 hundreds
73 imaging
74 initial assessment
75 intensive diagnostic approach
76 interval breast cancers
77 length
78 length of delay
79 long-term outcomes
80 mammography
81 mass
82 mean delay
83 minority groups
84 missed cancers
85 negative assessment
86 negative breast assessment
87 negatives
88 next biennial screen
89 nodal status
90 only evaluation
91 outcomes
92 pathological features
93 pathology
94 positive screen
95 presentation
96 prognosis
97 program
98 rate
99 recall
100 regular borders
101 report – false negative breast assessment
102 review 56
103 screen
104 screening
105 screening mammography
106 significant differences
107 six hundred
108 size
109 stage
110 status
111 suspicious mammography
112 suspicious screening mammography
113 test
114 testing
115 thousand six hundred
116 tumor histology
117 types
118 types of abnormalities
119 women
120 worse prognosis
121 years
122 schema:name Minority report – false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis
123 schema:pagination 37-43
124 schema:productId N34164659002845a289cf8a77d5dbc174
125 Nc852c429773f4154a08438219ea013fd
126 Nf519d2f540cf41acb29ec444a40bd727
127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036835572
128 https://doi.org/10.1007/s10549-006-9425-3
129 schema:sdDatePublished 2022-01-01T18:16
130 schema:sdLicense https://scigraph.springernature.com/explorer/license/
131 schema:sdPublisher N88393b4a49854eb4b27e494984b8ef4d
132 schema:url https://doi.org/10.1007/s10549-006-9425-3
133 sgo:license sg:explorer/license/
134 sgo:sdDataset articles
135 rdf:type schema:ScholarlyArticle
136 N08f1649ccedf40bb94393caed6f7640a rdf:first sg:person.0747474743.39
137 rdf:rest N2a8af9930b9c4c16a27b533d51b5a339
138 N0fa0f243bae34018a92df26e478c4f5c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Reproducibility of Results
140 rdf:type schema:DefinedTerm
141 N2a8af9930b9c4c16a27b533d51b5a339 rdf:first sg:person.01012362050.20
142 rdf:rest N50152311203140c1b6bfbc9eb97a2e54
143 N34164659002845a289cf8a77d5dbc174 schema:name doi
144 schema:value 10.1007/s10549-006-9425-3
145 rdf:type schema:PropertyValue
146 N35dd83d54acb401e942a1a860cacb92f schema:issueNumber 1
147 rdf:type schema:PublicationIssue
148 N3ddd8656b2f04e679d3c86b256ee5dbd rdf:first sg:person.01174274056.26
149 rdf:rest N08f1649ccedf40bb94393caed6f7640a
150 N422d7fd54aa44d3a99469b8b7dfb6f7e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Retrospective Studies
152 rdf:type schema:DefinedTerm
153 N4c4a6b1561574276ac938230915042d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Time Factors
155 rdf:type schema:DefinedTerm
156 N50152311203140c1b6bfbc9eb97a2e54 rdf:first sg:person.0663211456.44
157 rdf:rest N7e245fa748994fa6a96eee691f9ab31f
158 N640f66a8b73649cf810812391baed60c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Biopsy
160 rdf:type schema:DefinedTerm
161 N6f16fedcefeb4aa1a86876f4ae950948 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Mammography
163 rdf:type schema:DefinedTerm
164 N75135c8caade4e8c8bb434eb9709bda1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Breast Neoplasms
166 rdf:type schema:DefinedTerm
167 N7bc273facc8542e4bc5801e30b27e539 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Humans
169 rdf:type schema:DefinedTerm
170 N7e245fa748994fa6a96eee691f9ab31f rdf:first sg:person.0660537165.09
171 rdf:rest N88c975d249c24a6ca8c28241664ffec8
172 N8410e26deb414324876f93e312eeb484 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Predictive Value of Tests
174 rdf:type schema:DefinedTerm
175 N88393b4a49854eb4b27e494984b8ef4d schema:name Springer Nature - SN SciGraph project
176 rdf:type schema:Organization
177 N88c975d249c24a6ca8c28241664ffec8 rdf:first sg:person.01310346446.37
178 rdf:rest rdf:nil
179 N8c8d4c74fb1c4d00954ec5fbb52030f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Mass Screening
181 rdf:type schema:DefinedTerm
182 N8dc6479113d745eeab102ab636c5131c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Treatment Outcome
184 rdf:type schema:DefinedTerm
185 N9246369ee7d74fac804f6f8f67d799e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Middle Aged
187 rdf:type schema:DefinedTerm
188 Na71934b005ba4ea580d65987efc24474 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Prognosis
190 rdf:type schema:DefinedTerm
191 Nb6693fef86134accb80be87bcb65b01e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name False Negative Reactions
193 rdf:type schema:DefinedTerm
194 Nb8c882fd6428436f95d5e0d051dc9c3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Female
196 rdf:type schema:DefinedTerm
197 Nc19187fa32d243879601a0f981b24708 schema:volumeNumber 105
198 rdf:type schema:PublicationVolume
199 Nc42f06eb941d409fb59b394d78433dda schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Aged
201 rdf:type schema:DefinedTerm
202 Nc852c429773f4154a08438219ea013fd schema:name pubmed_id
203 schema:value 17115112
204 rdf:type schema:PropertyValue
205 Nf519d2f540cf41acb29ec444a40bd727 schema:name dimensions_id
206 schema:value pub.1036835572
207 rdf:type schema:PropertyValue
208 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
209 schema:name Medical and Health Sciences
210 rdf:type schema:DefinedTerm
211 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
212 schema:name Oncology and Carcinogenesis
213 rdf:type schema:DefinedTerm
214 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
215 schema:name Public Health and Health Services
216 rdf:type schema:DefinedTerm
217 sg:grant.6718511 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-006-9425-3
218 rdf:type schema:MonetaryGrant
219 sg:journal.1092777 schema:issn 0167-6806
220 1573-7217
221 schema:name Breast Cancer Research and Treatment
222 schema:publisher Springer Nature
223 rdf:type schema:Periodical
224 sg:person.01012362050.20 schema:affiliation grid-institutes:grid.417623.5
225 schema:familyName Ambrogetti
226 schema:givenName D.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012362050.20
228 rdf:type schema:Person
229 sg:person.01174274056.26 schema:affiliation grid-institutes:grid.417623.5
230 schema:familyName Ciatto
231 schema:givenName S.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174274056.26
233 rdf:type schema:Person
234 sg:person.01310346446.37 schema:affiliation grid-institutes:grid.417623.5
235 schema:familyName Del Turco
236 schema:givenName M. Rosselli
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310346446.37
238 rdf:type schema:Person
239 sg:person.0660537165.09 schema:affiliation grid-institutes:grid.417623.5
240 schema:familyName Collini
241 schema:givenName G.
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660537165.09
243 rdf:type schema:Person
244 sg:person.0663211456.44 schema:affiliation grid-institutes:grid.417623.5
245 schema:familyName Bonardi
246 schema:givenName R.
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663211456.44
248 rdf:type schema:Person
249 sg:person.0747474743.39 schema:affiliation grid-institutes:grid.1013.3
250 schema:familyName Houssami
251 schema:givenName N.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747474743.39
253 rdf:type schema:Person
254 sg:pub.10.1007/s10549-006-9289-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049312084
255 https://doi.org/10.1007/s10549-006-9289-6
256 rdf:type schema:CreativeWork
257 sg:pub.10.1038/sj.bjc.6602158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051991679
258 https://doi.org/10.1038/sj.bjc.6602158
259 rdf:type schema:CreativeWork
260 grid-institutes:grid.1013.3 schema:alternateName School of Public Health, Screening & Test Evaluation Program, School of Public Health, Edward Ford Building A27, University of Sydney, 2006, Sydney, NSW, Australia
261 schema:name School of Public Health, Screening & Test Evaluation Program, School of Public Health, Edward Ford Building A27, University of Sydney, 2006, Sydney, NSW, Australia
262 rdf:type schema:Organization
263 grid-institutes:grid.417623.5 schema:alternateName Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy
264 schema:name Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy
265 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...